These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7833115)

  • 1. Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs.
    Stein U; Walther W; Wunderlich V
    Eur J Cancer; 1994; 30A(10):1541-5. PubMed ID: 7833115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vincristine induction of mutant and wild-type human multidrug-resistance promoters is cell-type-specific and dose-dependent.
    Stein U; Walther W; Shoemaker RH
    J Cancer Res Clin Oncol; 1996; 122(5):275-82. PubMed ID: 8609150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse transcriptase-polymerase chain reaction amplification of MDR1 gene expression in adult soft tissue sarcomas.
    Oda Y; Schneider-Stock R; Ryś J; Gruchała A; Niezabitowski A; Roessner A
    Diagn Mol Pathol; 1996 Jun; 5(2):98-106. PubMed ID: 8727096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the human MDR1 promoter for heat-inducible expression of therapeutic genes.
    Walther W; Stein U; Schlag PM
    Int J Cancer; 2002 Mar; 98(2):291-6. PubMed ID: 11857422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease.
    Rund D; Azar I; Shperling O
    Adv Exp Med Biol; 1999; 457():71-5. PubMed ID: 10500782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.
    Hu XF; Slater A; Wall DM; Kantharidis P; Parkin JD; Cowman A; Zalcberg JR
    Br J Cancer; 1995 May; 71(5):931-6. PubMed ID: 7734315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
    Chao CC
    FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of new multidrug-resistant human osteosarcoma cell lines.
    Oda Y; Matsumoto Y; Harimaya K; Iwamoto Y; Tsuneyoshi M
    Oncol Rep; 2000; 7(4):859-66. PubMed ID: 10854558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the human multidrug resistance gene (MDR1) and prognostic correlation in human osteogenic sarcoma.
    Imanishi T; Abe Y; Suto R; Higaki S; Ueyama Y; Nakamura M; Tamaoki N; Fukuda H; Imai N
    Tokai J Exp Clin Med; 1994 Sep; 19(1-2):39-46. PubMed ID: 7660382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
    Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
    Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.
    Suto R; Abe Y; Nakamura M; Ohnishi Y; Yoshimura M; Lee YH; Imanishi T; Yamazaki H; Kijima H; Tokunaga T; Oshika Y; Hiraoka N; Tamaoki N; Fukuda H; Ueyama Y
    Int J Oncol; 1998 Feb; 12(2):287-91. PubMed ID: 9458350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of MDR1 Expression Regulated by miR-138 through TRPS1 Signaling Pathway on Multidrug Resistance of Osteosarcoma and Formation of Bacterial Infection Biofilm.
    Fang X; Zhu L; Wu Q; Zhong X; Chen Y; Zhu W
    Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):51-57. PubMed ID: 37571901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line.
    Ogretmen B; Safa AR
    Biochemistry; 2000 Jan; 39(1):194-204. PubMed ID: 10625494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias.
    Nakayama M; Wada M; Harada T; Nagayama J; Kusaba H; Ohshima K; Kozuru M; Komatsu H; Ueda R; Kuwano M
    Blood; 1998 Dec; 92(11):4296-307. PubMed ID: 9834236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of hypomethylation status and preferential expression of exogenous human MDR1/PGY1 gene in mouse L cells by YAC mediated transfer.
    Kusaba H; Nakayama M; Harada T; Torigoe K; Green ED; Scherer SW; Kohno K; Kuwano M; Wada M
    Somat Cell Mol Genet; 1997 Jul; 23(4):259-74. PubMed ID: 9542528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
    Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of multidrug resistance gene expression in human osteosarcomas.
    Lee PD; Noble-Topham SE; Bell RS; Andrulis IL
    Br J Cancer; 1996 Oct; 74(7):1046-50. PubMed ID: 8855972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
    J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.